{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:16:45Z","timestamp":1768983405648,"version":"3.49.0"},"reference-count":4,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,6,30]]},"abstract":"<jats:p>A 69-year-old male patient who was treated with intravesical BCG for carcinoma in situ of the bladder, went on to develop systemic features of BCG-osis. This diagnosis was supported by significant radiological and clinical findings. These systemic features include pulmonary miliary lesions, a mycotic abdominal aortic aneurysm and penile lesions. Owing to a breakdown in the relationship between the patient and the National Health Service, the patient has declined BCG treatment. This case highlights the potential rare side effects of intravesical BCG treatment and the risk associated with non-treatment of BCG-osis.<\/jats:p>","DOI":"10.1136\/bcr-2016-215635","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T10:51:29Z","timestamp":1468493489000},"page":"bcr2016215635","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["BCG-osis following intravesical BCG treatment leading to miliary pulmonary nodules, penile granulomas and a mycotic aortic aneurysm"],"prefix":"10.1136","volume":"2016","author":[{"given":"David Mark","family":"Smith","sequence":"first","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"key":"2025082800235309000_2016.jul14_1.bcr2016215635.1","doi-asserted-by":"crossref","unstructured":"Lukacs S , Tschobotko B , Szabo N , et al . Systemic BCG-osis as a rare side effect of intravesical BCG treatment for superficial bladder cancer. Case Rep Urol 2013;2013:821526. doi:10.1155\/2013\/821526","DOI":"10.1155\/2013\/821526"},{"key":"2025082800235309000_2016.jul14_1.bcr2016215635.2","doi-asserted-by":"crossref","unstructured":"Mehta A , Mehta P , Mehta R . A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer. Case Rep 2012;2012:pii: bcr2012007327. doi:10.1136\/bcr-2012-007327","DOI":"10.1136\/bcr-2012-007327"},{"key":"2025082800235309000_2016.jul14_1.bcr2016215635.3","first-page":"pii: bcr2013201202","article-title":"Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder","volume":"2014","author":"Choi","year":"2014","journal-title":"Case Rep"},{"key":"2025082800235309000_2016.jul14_1.bcr2016215635.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.06.003"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-215635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:24:06Z","timestamp":1756365846000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-215635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":4,"alternative-id":["10.1136\/bcr-2016-215635"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-215635","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}